Swiss Medical Network: Advancing Cancer Care Through Research, Innovation and Collaboration

A global moment of commitment and hope

On World Cancer Day, Swiss Medical Network joins the global community in reaffirming a shared commitment: to reduce the burden of cancer, to support patients and families at every stage of their journey, and to accelerate progress through science, prevention, early detection and access to high-quality care. This day is not only a moment of awareness—it is a call to action. Cancer remains one of the major health challenges of our time, and addressing it requires determination, collaboration and continuous innovation.

At Swiss Medical Network, we believe that every step forward—whether scientific, clinical or educational—can translate into meaningful improvements in patients’ lives.

A comprehensive oncology vision: from prevention to treatment

Swiss Medical Network plays an active and growing role in oncology, combining clinical excellence with a strong commitment to research and innovation. Our approach spans the full continuum of cancer care: from prevention, including the promotion of evidence-based measures such as vaccination strategies where appropriate, to diagnosis, and onward to therapeutic management through multidisciplinary, patient-centered treatment pathways. Modern oncology is evolving rapidly, and progress depends on the ability to integrate new knowledge into daily practice — ensuring that patients benefit from advances in medical science as efficiently and safely as possible.

Translating science into impact: the Genolier Research Unit

A key driver of this commitment is the Clinical and Translational Research Unit at Genolier, which plays a central role in supporting and developing scientific activities within Swiss Medical Network. Translational research is essential in oncology because it creates a bridge between laboratory discoveries and real-world clinical impact.

By fostering structured research initiatives, facilitating clinical studies, and encouraging innovation in the evaluation of new approaches, the Genolier unit contributes to strengthening scientific momentum across the network. It also supports the development of a research culture that connects clinicians, investigators and healthcare professionals around a shared goal: improving outcomes and quality of life for people afftected by cancer.

Innovation as a catalyst: the Genolier Innovation Hub

In this same spirit, the Genolier Innovation Hub plays a critical role as a platform that brings together clinical expertise, research initiatives and innovation dynamics. By encouraging interdisciplinary exchanges and creating opportunities for dialogue between healthcare professionals, researchers and external partners, it supports the development of forward-looking projects and helps transform innovation into practical benefit for patients. The Hub also provides an ideal setting to promote scientific events, share knowledge and strengthen the visibility of oncology-related initiatives within Swiss Medical Network.

Delivering modern cancer care with a human-centered approach

In oncology, scientific progress does not rely on treatment alone. It requires continuous improvement in early detection, diagnostic strategies, and the personalization of care. Swiss Medical Network recognizes that accurate and timely diagnosis is a cornerstone of modern cancer medicine and remains committed to strengthening expertise and innovation across these domains.

Equally, therapeutic management today increasingly involves combining multiple modalities—surgery, systemic treatments, theranostics, radiotherapy, supportive care and follow-up—guided by evidence and delivered through coordinated teams. This integrated model reflects our conviction that oncology care must be both scientifically advanced and deeply human.

Education and training: building excellence for the future

On World Cancer Day, we also highlight a fundamental pillar of progress: education and training. In a field as dynamic as oncology, knowledge must be continuously shared, updated and translated into practice. Swiss Medical Network places strong emphasis on education along the main axes of oncological research and care—from prevention and screening strategies to new diagnostic tools, emerging therapies, and survivorship considerations. Training healthcare professionals is not only an investment in expertise; it is an investment in safer care, better decision-making, and the ability to adopt innovation responsibly. Educational initiatives—including scientific events, expert exchanges and interdisciplinary learning—are essential to building long-term excellence across the network.

Partnerships that accelerate progress

Finally, Swiss Medical Network is convinced that partnerships are critical to meaningful progress in cancer research and care. The complexity of oncology demands collaboration across institutions, disciplines and borders. Strengthening ties with other Swiss and international organizations enables the exchange of knowledge, the development of joint scientific initiatives, and the acceleration of innovation. In this context, Swiss Medical Network values collaborations with key partners such as Biopôle, Mayo Clinic Care Network, the European Institute of Oncology (IEO), EPFL, and ETH Zurich (ETHZ). These connections contribute to fostering scientific excellence, encouraging innovation, and reinforcing a shared ambition: to move faster from discovery to clinical implementation, while maintaining the highest standards of quality and patient safety.

A shared responsibility, a shared future

On 4 February 2026, Swiss Medical Network stands with patients, families, caregivers, researchers and healthcare professionals worldwide. Together, we can drive progress through prevention, research, innovation, education and collaboration—and continue advancing towards a future where cancer is detected earlier, treated more effectively, and lived with more support, dignity and hope.

Hospitals

Centres

For patients

About us

Integrated care